A comprehensive metabolite fingerprint of fibrostenosis in patients with Crohn’s disease
Abstract Intestinal fibrostenosis in patients with Crohn’s disease (CD) is a common and untreatable comorbidity that is notoriously difficult to monitor. We aimed to find metabolites associated with the presence of fibrostenosis in patients with CD using targeted and untargeted metabolomics analyses...
Main Authors: | Simon Bos, Triana Lobatón, Martine De Vos, Sophie Van Welden, Vera Plekhova, Ellen De Paepe, Lynn Vanhaecke, Debby Laukens |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-50461-1 |
Similar Items
-
Downregulation of Heat Shock Protein 72 Contributes to Fibrostenosis in Crohn’s Disease
by: Seung Won Kim, et al.
Published: (2023-11-01) -
Long-Term Environmental Hypoxia Exposure and Haematopoietic Prolyl Hydroxylase-1 Deletion Do Not Impact Experimental Crohn’s Like Ileitis
by: Cara De Galan, et al.
Published: (2021-09-01) -
Unraveling the fatigue puzzle: insights into the pathogenesis and management of IBD-related fatigue including the role of the gut-brain axis
by: Marie Truyens, et al.
Published: (2024-07-01) -
Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions
by: Alfred D. Doyle, et al.
Published: (2020-12-01) -
Disparities in the gut metabolome of post-operative Hirschsprung's disease patients
by: Vera Plekhova, et al.
Published: (2021-08-01)